ICCM - IceCure Medical GAAP EPS of -$0.46 misses by $0.35 revenue of $3.1M beats by $2.1M
2023-03-29 08:07:09 ET
- IceCure Medical press release ( NASDAQ: ICCM ): FY GAAP EPS of -$0.46 misses by $0.35 .
- Revenue of $3.1M (-24.4% Y/Y) beats by $2.1M .
- Gross margin was approximately 47% for the twelve months ended December 31, 2022, compared to approximately 53% for the twelve months ended December 31, 2021.
- As of December 31, 2022, the Company had cash and cash equivalents including short-term deposits of approximately $23.7 million, compared to approximately $25.6 million as of December 31, 2021.
- The Company will use its resources to execute its global business strategy and continue to raise awareness of the clinical and economic benefits of its ProSense system.
For further details see:
IceCure Medical GAAP EPS of -$0.46 misses by $0.35, revenue of $3.1M beats by $2.1M